» Articles » PMID: 28717744

Influence of HIV/AIDS on Cervical Cancer: A Retrospective Study From Tanzania

Overview
Journal J Glob Oncol
Specialty Oncology
Date 2017 Jul 19
PMID 28717744
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Cervical cancer is the leading cause of cancer-related morbidity and mortality in women in Tanzania. Any impact of the HIV/AIDS epidemic on cervical precancerous lesions and invasive cervical cancer has a significant implication, as for any public health concern, especially in an area such as the Morogoro region in Tanzania, which has one of the highest rates of cervical cancer in the world.

Methods: A comparative retrospective study was performed of 536 women screened for cervical cancer by visual inspection methods at the Morogoro Regional Referral Hospital over a period of 3 years; the women were grouped according to their HIV status. The odds ratios (OR) with 95% CIs were estimated using χ test and multivariate analysis. The test statistics were evaluated with a significance level of < .05.

Results: The prevalence of precancerous lesions was 71.8% in HIV-positive women and 27.3% in HIV-seronegative women. Furthermore, the prevalence of extensive or large precancerous lesions was 40.5% in HIV-positive women and 13.5% in HIV-seronegative women. The prevalence of invasive cervical cancer was 8% in HIV-seronegative women and 11% in HIV-positive women. The risk factors for the cervical lesions were HIV-positive status (OR, 6.8; 95% CI, 4.2 to 11.2; < .001) and being older than 30 years of age (OR, 11.99; 95% CI, 6.86 to 21.21; < .001).

Conclusion: HIV/AIDS has a highly statistically significant association with ( < .001) and a great influence on the development of cervical precancerous lesions in HIV-positive women; however, its direct involvement in the progression to invasive cervical cancer, especially in this era of highly active antiretroviral therapy, is questionable.

Citing Articles

Prevalence of human papilloma virus infection and risk of cervical intraepithelial neoplasia among female sex workers in Mumbai, India.

Pahwa V, Pimple S, Mishra G, Majmudar P, Biswas S, Deodhar K Ecancermedicalscience. 2024; 18:1772.

PMID: 39430078 PMC: 11489111. DOI: 10.3332/ecancer.2024.1772.


Cervical cancer screening service utilisation and related factors among women on antiretroviral therapy in public health facilities of Asella town, Ethiopia, cross-sectional study.

Yasin S, Ferede A, Tafa M BMC Infect Dis. 2024; 24(1):1115.

PMID: 39375613 PMC: 11459845. DOI: 10.1186/s12879-024-10003-0.


Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic.

Tran J, Hathaway C, Broshkevitch C, Palanee-Phillips T, Barnabas R, Rao D Front Oncol. 2024; 14:1382599.

PMID: 38720798 PMC: 11077327. DOI: 10.3389/fonc.2024.1382599.


Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.

Teklehaimanot D, Mekuria A, Dadi A, Derseh B BMC Womens Health. 2024; 24(1):271.

PMID: 38702683 PMC: 11067165. DOI: 10.1186/s12905-024-03113-z.


Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.

Kirabira J, Kayondo M, Bawakanya S, Nsubuga E, Yarine F, Namuli A BMC Womens Health. 2024; 24(1):266.

PMID: 38678278 PMC: 11055386. DOI: 10.1186/s12905-024-03108-w.


References
1.
Gichangi P, De Vuyst H, Estambale B, Rogo K, Bwayo J, Temmerman M . HIV and cervical cancer in Kenya. Int J Gynaecol Obstet. 2002; 76(1):55-63. DOI: 10.1016/s0020-7292(01)00560-4. View

2.
Kafuruki L, Rambau P, Massinde A, Masalu N . Prevalence and predictors of Cervical Intraepithelial Neoplasia among HIV infected women at Bugando Medical Centre, Mwanza-Tanzania. Infect Agent Cancer. 2013; 8(1):45. PMC: 3833176. DOI: 10.1186/1750-9378-8-45. View

3.
Heatley M . A comparison of three methods of orienting cervical punch biopsies. J Clin Pathol. 1999; 52(2):149-50. PMC: 501063. DOI: 10.1136/jcp.52.2.149. View

4.
Womack S, Chirenje Z, Gaffikin L, Blumenthal P, McGrath J, Chipato T . HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer. 2000; 85(2):206-10. View

5.
Scurry J, Patel K, Wells M . ACP Broadsheet No 138: May 1993. Gross examination of uterine specimens. J Clin Pathol. 1993; 46(5):388-93. PMC: 501242. DOI: 10.1136/jcp.46.5.388. View